Safety and effectiveness of non-insulin glucose-lowering agents in the treatment of people with type 2 diabetes who observe Ramadan: a systematic review and meta-analysis
出版年份 2015 全文链接
标题
Safety and effectiveness of non-insulin glucose-lowering agents in the treatment of people with type 2 diabetes who observe Ramadan: a systematic review and meta-analysis
作者
关键词
-
出版物
DIABETES OBESITY & METABOLISM
Volume 17, Issue 7, Pages 639-648
出版商
Wiley
发表日期
2015-03-16
DOI
10.1111/dom.12462
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Clinical implication of SGLT2 inhibitors in type 2 diabetes
- (2014) Go Woon Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Improved Glucose Control With Weight Loss, Lower Insulin Doses, and No Increased Hypoglycemia With Empagliflozin Added to Titrated Multiple Daily Injections of Insulin in Obese Inadequately Controlled Type 2 Diabetes
- (2014) Julio Rosenstock et al. DIABETES CARE
- Safety and Tolerability of Canagliflozin in Patients With Type 2 Diabetes Mellitus: Pooled Analysis of Phase 3 Study Results
- (2014) Keith Usiskin et al. POSTGRADUATE MEDICINE
- Glycemic effects of vildagliptin in patients with type 2 diabetes before, during and after the period of fasting in Ramadan
- (2014) Line P. Malha et al. Therapeutic Advances in Endocrinology and Metabolism
- A randomized controlled trial comparing the GLP-1 receptor agonist liraglutide to a sulphonylurea as add on to metformin in patients with established type 2 diabetes during Ramadan: the Treat 4 Ramadan Trial
- (2013) E. M. Brady et al. DIABETES OBESITY & METABOLISM
- The effect of vildagliptin relative to sulphonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: the VIRTUE study
- (2013) M. Al-Arouj et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Experience with Vildagliptin in Type 2 Diabetic Patients Fasting During Ramadan in France: Insights from the VERDI Study
- (2013) Serge Halimi et al. Diabetes Therapy
- Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study
- (2012) S.R. Aravind et al. CURRENT MEDICAL RESEARCH AND OPINION
- Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
- (2012) Mohamed AlMaatouq Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study
- (2011) Mohamed Hassanein et al. CURRENT MEDICAL RESEARCH AND OPINION
- The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial
- (2011) S. Al Sifri et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Recommendations for Management of Diabetes During Ramadan: Update 2010
- (2010) M. Al-Arouj et al. DIABETES CARE
- Diabetes and fasting during Ramadan
- (2010) Elaine Hui et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Ramadan Education and Awareness in Diabetes (READ) programme for Muslims with Type 2 diabetes who fast during Ramadan
- (2010) V. Bravis et al. DIABETIC MEDICINE
- Vildagliptin therapy and hypoglycaemia in Muslim type 2 diabetes patients during Ramadan
- (2009) D. Devendra et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now